Imodium

Loperamide Hydrochloride, the active ingredient in Imodium, is an antidiarrheal presented as an unknown/unknown for oral use. It treats acute nonspecific diarrhea, chronic diarrhea associated with inflammatory bowel disease, and travelers' diarrhea in adults and children as appropriate.

GNH USA supplies Imodium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imodium is an antidiarrheal that acts on intestinal motility to control excess stool output. It is indicated for the following conditions: - Acute nonspecific diarrhea: reduces stool frequency and liquidity during short‑term episodes. - Chronic diarrhea associated with inflammatory bowel disease: helps maintain stool consistency in long‑term disease management. - Travelers' diarrhea: provides symptomatic relief for diarrhea acquired during travel.

Adverse reactions may occur with any antidiarrheal medication.

Common Side Effects: - Constipation: reduced bowel movements leading to hard stools. - Abdominal cramps: mild to moderate discomfort in the abdomen. - Nausea: feeling of queasiness or urge to vomit. - Dizziness: light‑headed sensation, especially on standing.

Serious or Rare Side Effects: - Severe constipation or ileus: risk of bowel obstruction requiring medical attention. - Toxic megacolon: rare but life‑threatening colonic dilation. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Cardiac arrhythmia: QT prolongation especially with high plasma levels. - Urinary retention: difficulty emptying the bladder.

Before using Imodium, consider the following safety measures: - Hepatic impairment: adjust dosage or avoid if severe liver disease is present. - Known hypersensitivity: discontinue if allergic reaction occurs. - Existing constipation: avoid use in patients already constipated. - Duration of therapy: do not exceed recommended treatment length without medical advice. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Loperamide may interact with other medicines, affecting its safety and effectiveness.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): increase loperamide plasma levels and risk of cardiac toxicity. - P‑glycoprotein inhibitors (e.g., quinidine, verapamil): raise systemic exposure, potentially leading to adverse effects. - Other opioids: additive central nervous system depression and respiratory risk.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may exacerbate constipation. - Other antidiarrheal products (e.g., bismuth subsalicylate): overlapping mechanisms could cause excessive slowing of gut motility.